Tissue engineering of musculoskeletal tissues, especially bone and cartilage, is a quickly propelling field. In bone, innovation has fixated on bone unite substitute materials and the improvement of biodegradable scaffolds. Tissue engineering methodologies have included cell and gene therapy. The accessibility of development factors and the growing information base concerning the genetics and regulation of bone formation have generated new materials for tissue-engineering applications. The issues are more perplexing, and the solutions appear more elusive. Innovations in scaffold design and cell culture have improved the prognosis for success. A number of matrices have been tested in vitro and in vivo in preclinical and clinical examinations. These networks can be characterized by their nature.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States